全文获取类型
收费全文 | 2875篇 |
免费 | 144篇 |
国内免费 | 76篇 |
专业分类
耳鼻咽喉 | 37篇 |
儿科学 | 181篇 |
妇产科学 | 61篇 |
基础医学 | 292篇 |
口腔科学 | 124篇 |
临床医学 | 296篇 |
内科学 | 726篇 |
皮肤病学 | 82篇 |
神经病学 | 100篇 |
特种医学 | 397篇 |
外科学 | 177篇 |
综合类 | 61篇 |
预防医学 | 165篇 |
眼科学 | 25篇 |
药学 | 227篇 |
2篇 | |
中国医学 | 1篇 |
肿瘤学 | 141篇 |
出版年
2022年 | 9篇 |
2021年 | 18篇 |
2020年 | 23篇 |
2019年 | 28篇 |
2018年 | 44篇 |
2017年 | 27篇 |
2016年 | 25篇 |
2015年 | 46篇 |
2014年 | 64篇 |
2013年 | 74篇 |
2012年 | 60篇 |
2011年 | 66篇 |
2010年 | 101篇 |
2009年 | 97篇 |
2008年 | 74篇 |
2007年 | 125篇 |
2006年 | 98篇 |
2005年 | 107篇 |
2004年 | 79篇 |
2003年 | 59篇 |
2002年 | 70篇 |
2001年 | 78篇 |
2000年 | 79篇 |
1999年 | 73篇 |
1998年 | 137篇 |
1997年 | 167篇 |
1996年 | 140篇 |
1995年 | 117篇 |
1994年 | 122篇 |
1993年 | 105篇 |
1992年 | 47篇 |
1991年 | 55篇 |
1990年 | 53篇 |
1989年 | 71篇 |
1988年 | 64篇 |
1987年 | 67篇 |
1986年 | 64篇 |
1985年 | 61篇 |
1984年 | 46篇 |
1983年 | 21篇 |
1982年 | 31篇 |
1981年 | 32篇 |
1980年 | 34篇 |
1979年 | 14篇 |
1978年 | 15篇 |
1977年 | 19篇 |
1976年 | 31篇 |
1975年 | 17篇 |
1974年 | 10篇 |
1973年 | 8篇 |
排序方式: 共有3095条查询结果,搜索用时 15 毫秒
1.
JM Martín† L Calduch† C Monteagudo‡ I Molina† D Ramón† V Alonso† E Jordᆠ《Journal of the European Academy of Dermatology and Venereology》2006,20(4):428-431
Cutaneous plasmacytosis is a rare disorder characterized by a benign proliferation of mature plasma cells that appears as multiple dark-brown to purplish skin lesions, often associated with polyclonal hypergammaglobulinaemia. We present the case of a 55-year-old Caucasian man who suffered from a cutaneous plasmacytosis associated with two different carcinomas. Cutaneous plasmacytosis seems to be a reactive process because most cases reported are not associated with any apparent underlying disease. Nevertheless, because few reported cases were associated with malignancies, screening of additional neoplasms would be justified. 相似文献
2.
Müllerian duct regression is first apparent in male pouch young of the tammar wallaby (Macropus eugenii) 6–7 days after birth and, as in eutherian mammals, is characterised by a condensation of the periductal mesenchyme into
a whorl around the ductal epithelial cells. A decrease in the density of the extracellular matrix was observed in the region
of the whorl. In contrast to eutherian mammals no changes were observed in the mean outer diameter of the Müllerian duct during
the early stages of regression. The time at which these mesenchymal changes occur corresponds to the period of Müllerian inhibiting
substance secretion in the postnatal tammar testis.
Accepted: 25 February 1997 相似文献
3.
JM Vilanova J Figueras-Aloy J Roselló G Gómez E Gelpí R Jiménez 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(5):588-592
The aim of this study was to evaluate the cerebral synthesis of eicosanoids in the asphyctic newborn and to investigate the relation between the prostanoid profiles in cerebrospinal fluid (CSF) and the appearance and severity of hypoxic-ischaemic encephalopathy (HIE). Levels of 6-keto-PGF 1-α, TXB2 , PGE2 and PGF2-α in CSF were measured in 40 full term newborns during the first day of life. Thirty of these newborns had birth asphyxia and were divided into three groups: 10 without HIE, 12 with mild HIE and 8 with moderate-severe HIE. They were compared to a control group of 10 non-hypoxic newborns. Determinations of the metabolites in CSF were performed by RIA and expressed as pg/ml (mean ± SD). The CSF TXB2 (thromboxane A2 metabolite) in asphyxiated newborns was always higher than in the control group (28.12 ± 10.6), and related to the severity of HIE ( p = 0:005): without HIE (50.84 ± 16.4; p = 0:02), mild HIE (80.65 ± 12.64; p ± 0:01) and moderate-severe HIE (178.14 ± 20.5; p < 0:01). The CSF 6-keto-PGF 1-α (prostacyclin metabolite) in asphyxiated newborns was always higher than in the control group (80.55 ± 12.56), but indirectly related to the severity of HIE: without HIE (240.95 ± 28.12; p < 0:01), mild HIE (183.65 ± 30.1; p < 0:01) and moderate-severe HIE (140.55 ± 25.12; p < 0:01). In the moderate-severe HIE group, the increase in TXB2 was higher than the rise in 6-keto-PGF 1-α . 相似文献
4.
5.
6.
7.
C H Stuppaeck R Pycha C Miller A B Whitworth H Oberbauer W W Fleischhacker 《Alcohol and alcoholism (Oxford, Oxfordshire)》1992,27(2):153-158
The use of more than 130 drugs and drug combinations against the alcohol withdrawal syndrome reflects the fact that views on its treatment are far from being unequivocal. Benzodiazepines are the first choice treatment but it should not be disregarded that they have side effects and, above all, a varying risk of dependency themselves. In recent years many trials have focused on carbamazepine in this respect. Its efficacy was proven in various open and double-blind studies, most of them using concomitant sedative drugs, thereby diminishing the reliability of the results. In a double-blind study we compared the efficacy of carbamazepine with that of oxazepam, in 60 in-patients suffering from alcohol withdrawal syndrome. The main rating instrument was the Clinical Institute Withdrawal Scale--Alcohol (CIWA-A). The 7-day trial showed equal efficacy of carbamazepine and oxazepam during the first 5 days and a statistically significant superiority of carbamazepine on days 6 and 7. Four patients in each group had to be dropped from the study due to side effects or after having withdrawn informed consent. There was no decrease in white blood counts under carbamazepine. The experiences with carbamazepine up to now suggest a more widespread use, especially in non-delirious withdrawal states. 相似文献
8.
9.
10.
Moderate ovarian hyperstimulation syndrome occurred after LA was administered to control menorrhagia in an anephric woman who required hemodialysis. We postulate that women who require dialysis may be at special risk for the development of this syndrome. 相似文献